95 results
Page 5 of 5
424B5
lvmj7yd dhxt
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
vgwbzuy a4w20ifg9q
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
F-3/A
EX-4.2
tph8itw6
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
D
cle1dzk
9 Apr 19
$2.25M in options, sold $2.25M, 8 investors
9:04am
424B5
398vro0lma0ow zrb
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
r0acvph2
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
ab4o9j
17 Jan 19
Annual General Meeting of Shareholders
4:05pm
6-K
EX-99.1
sou2tktw dnuvq
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-10.1
8ns7mkld
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
F-3
EX-4.4
s21hyqx80
20 Jun 18
Shelf registration (foreign)
2:38pm
F-3
EX-4.3
zft9e13sb6lrex78sxp3
20 Jun 18
Shelf registration (foreign)
2:38pm
20-F
EX-4.3
lrskd9do
1 May 17
Annual report (foreign)
12:00am
20-F
mt5 18zhe5k09
1 May 17
Annual report (foreign)
12:00am